News

New York Antitrust and Litigation Lawyer C. Scott Lent Joins Arnold & Porter LLP

January 24, 2013

NEW YORK, January 24, 2013 --Arnold & Porter LLP announced today that C. Scott Lent has joined the firm’s antitrust and litigation practices in its New York office as counsel.  Mr. Lent’s broad-based antitrust practice spans numerous complex M & A transactions, civil and criminal investigations, commercial litigation and general counseling.  He represents clients before many government and regulatory agencies such as the Federal Trade Commission and the Department of Justice, as well as state antitrust authorities.

Mr. Lent’s practice focuses on the media and entertainment, telecommunications, building materials and healthcare industries.  He has advised such companies as HarperCollins Publishers, Cemex and IASIS Healthcare.  Mr. Lent also maintains a sports law practice and has counseled league and team clients regarding various matters.

He joins Arnold & Porter from Skadden, Arps, Slate, Meagher & Flom LLP in New York.

“Scott’s first-chair experience in complex antitrust matters on behalf of national and international companies is a natural fit with our antitrust practice in New York as well as in Washington, D.C. and Brussels,” said Stewart D. Aaron, head of the firm’s New York office.

“The comprehensive reach of Arnold & Porter’s highly-regarded antitrust practice is a great synergy with my experience and promises some exciting opportunities for significant collaboration with my new corporate colleagues, as well as with lawyers in other practice groups and offices,” said Mr. Lent.

Mr. Lent received his J.D. from New York University School of Law.

Arnold & Porter LLP is an international law firm of nearly 850 lawyers with offices in Brussels, Denver, London, Los Angeles, New York, Northern Virginia, San Francisco, Silicon Valley, and Washington, D. C.  The firm, founded in 1946, maintains more than 26 practice areas spanning a broad spectrum of the law, with a primary focus on litigation, transactional matters, and regulatory issues.

Email Disclaimer